Figure 2.
Projections 2016–2026 of originator and generic prices comparing population costs in US dollars (US$) for people on first-, second-, and third-line antiretroviral therapy (ART) and across all lines of therapy (broken axis).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.